Granules India Limited — Board Meeting, 21-02-2025: Outcome of Board Meeting

The Board of Directors has approved the acquisition of a 100% equity stake in Senn Chemicals AG, a Swiss-based company specializing in peptide development and manufacturing. Additionally, the Company will establish a wholly-owned subsidiary in India for the acquisition. The cash consideration for the purchase is approximately ₹192.5 crore. This strategic move aims to enhance Granules’ capabilities in peptide-based applications, aligning with its core business in Pharmaceuticals and Chemicals. The completion of the transaction is anticipated in the first half of the calendar year 2025.